Medtronic Plc (Brazil) Top Management

MDTC34 Stock  BRL 244.06  3.07  1.27%   
Medtronic Plc employs about 95 K people. The company is managed by 10 executives with a total tenure of roughly 33 years, averaging almost 3.0 years of service per executive, having 9500.0 employees per reported executive. Analysis of Medtronic Plc's management performance can provide insight into the company performance.
Geoffrey Martha  President
Executive Vice President and President - Restorative Therapies Group
Robert White  President
Executive Vice President and President of Medtronic’s Minimally Invasive Therapies Group
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medtronic plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
For information on how to trade Medtronic Stock refer to our How to Trade Medtronic Stock guide.

Medtronic Plc Management Team Effectiveness

The company has return on total asset (ROA) of 0.0422 % which means that it generated a profit of $0.0422 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0833 %, meaning that it generated $0.0833 on every $100 dollars invested by stockholders. Medtronic Plc's management efficiency ratios could be used to measure how well Medtronic Plc manages its routine affairs as well as how well it operates its assets and liabilities.

Medtronic Plc Workforce Comparison

Medtronic plc is regarded second in number of employees category among its peers. The total workforce of Medical Devices industry is now estimated at about 190,030. Medtronic Plc totals roughly 95,000 in number of employees claiming about 50% of all equities under Medical Devices industry.
The company has Profit Margin (PM) of 0.14 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.2 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.2.

Medtronic plc Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Medtronic plc Price Series Summation is a cross summation of Medtronic Plc price series and its benchmark/peer.

Medtronic Plc Notable Stakeholders

A Medtronic Plc stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Medtronic Plc often face trade-offs trying to please all of them. Medtronic Plc's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Medtronic Plc's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Geoffrey MarthaExecutive Vice President and President - Restorative Therapies GroupProfile
Robert WhiteExecutive Vice President and President of Medtronic’s Minimally Invasive Therapies GroupProfile
Ryan WeispfenningVice President - Investor RelationsProfile
Robert HoedtExecutive Vice President and President - EMEACProfile
Karen ParkhillCFO, Executive Vice PresidentProfile
Ivan FongGen VPProfile
Sean LennonChief OfficerProfile
Jennifer KirkGlobal OfficerProfile
Mark PloofSr ServicesProfile
MSc MDMedical ScientificProfile

About Medtronic Plc Management Performance

The success or failure of an entity such as Medtronic plc often depends on how effective the management is. Medtronic Plc management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Medtronic management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Medtronic management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. The company was founded in 1949 and is headquartered in Dublin, Ireland. MEDTRONIC DRN operates under Medical Devices classification in Brazil and is traded on Sao Paolo Stock Exchange. It employs 90000 people.
Please note, the presentation of Medtronic Plc's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Medtronic Plc's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Medtronic Plc's management manipulating its earnings.

Medtronic Plc Workforce Analysis

Traditionally, organizations such as Medtronic Plc use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Medtronic Plc within its industry.

Medtronic Plc Manpower Efficiency

Return on Medtronic Plc Manpower

Revenue Per Employee333.5K
Revenue Per Executive3.2B
Net Income Per Employee53K
Net Income Per Executive503.9M

Complementary Tools for Medtronic Stock analysis

When running Medtronic Plc's price analysis, check to measure Medtronic Plc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medtronic Plc is operating at the current time. Most of Medtronic Plc's value examination focuses on studying past and present price action to predict the probability of Medtronic Plc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medtronic Plc's price. Additionally, you may evaluate how the addition of Medtronic Plc to your portfolios can decrease your overall portfolio volatility.
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
CEOs Directory
Screen CEOs from public companies around the world
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance